The Journal of Immunology, Vol 133, Issue 2 913-922, Copyright © 1984 by American Association of Immunologists

ARTICLES

Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters

PH Cooper, P Mayer and M Baggiolini

It has been shown that low concentrations of E. coli lipopolysaccharides (LPS) greatly and selectively stimulate phagocytosis and related functions in mouse bone marrow-derived macrophages. Culture in the presence of 50 ng/ml LPS induced on average a 10-fold enhancement of phagocytosis of IgG-coated sheep erythrocytes. Activation was in two stages--a small increase observed during the first 8 to 12 hr, and the major increase noted between 16 and 24 hr. Phagocytic activity remained at the maximal level for 24 hr and then declined progressively. Stimulation by LPS was dose-dependent; significant effects could be observed at 0.8 ng/ml and the maximum was reached at 10 ng/ml. LPS-treated cells also showed a markedly increased tendency to form colonies. All these effects could be prevented by the addition of 100 ng/ml polymyxin B together with LPS, indicating that the active principle is lipid A. The LPS-dependent increase in phagocytic activity is probably mediated by increased Fc receptor capacity because both parameters were influenced in parallel by the stimulus. Phagocytosis-related events, such as enhanced hexose monophosphate shunt activity, H2O2 formation, and nitroblue tetrazolium reduction were also stimulated by LPS. By contrast, pinocytosis was unaffected. Measurements of cell-associated enzyme activities showed that lactate dehydrogenase, acid phosphatase, and cathepsin D were significantly increased. Beta-glucuronidase, beta-galactosidase, alkaline phosphodiesterase, and aminopeptidase were unchanged and NAD nucleosidase was markedly decreased after LPS treatment. 5'- Nucleotidase and glucosamine uptake were undetectable both in control and LPS-stimulated cells. LPS treatment induced a significant increase in cell-associated protein, but did not result in cell proliferation or increased cell loss as shown by the DNA content that remained constant. LPS-induced changes were dependent on de novo protein synthesis; cycloheximide prevented enhancement of phagocytosis, Fc receptor capacity, and colony formation.

This article has been cited by other articles:

				P. C. Patel, K. H. Fisher, E. C. C. Yang, C. M. Deane, and R. E. Harrison Proteomic Analysis of Microtubule-associated Proteins during Macrophage Activation Mol. Cell. Proteomics, November 1, 2009; 8(11): 2500 - 2514. [Abstract] [Full Text] [PDF]

				M. G. Binker, D. Y. Zhao, S. J. Y. Pang, and R. E. Harrison Cytoplasmic Linker Protein-170 Enhances Spreading and Phagocytosis in Activated Macrophages by Stabilizing Microtubules J. Immunol., September 15, 2007; 179(6): 3780 - 3791. [Abstract] [Full Text] [PDF]

				L. Albee, B. Shi, and H. Perlman Aspartic protease and caspase 3/7 activation are central for macrophage apoptosis following infection with Escherichia coli J. Leukoc. Biol., January 1, 2007; 81(1): 229 - 237. [Abstract] [Full Text] [PDF]

				T Reding, D Bimmler, A Perren, L-K Sun, F Fortunato, F Storni, and R Graf A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis Gut, August 1, 2006; 55(8): 1165 - 1173. [Abstract] [Full Text] [PDF]

				A. Baritussio, A. Alberti, D. Armanini, F. Meloni, and D. Bruttomesso Different pathways of degradation of SP-A and saturated phosphatidylcholine by alveolar macrophages Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L91 - L99. [Abstract] [Full Text] [PDF]

				D Ohmer-Schrock, C Schlatterer, H Plattner, and J Schlepper-Schafer Lung surfactant protein A (SP-A) activates a phosphoinositide/calcium signaling pathway in alveolar macrophages J. Cell Sci., January 12, 1995; 108(12): 3695 - 3702. [Abstract] [PDF]